Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,240,000 | 6,360,000 | 9,217,000 | 7,701,000 | 7,571,000 |
| Marketable Securities | 615,000 | 816,000 | 836,000 | 854,000 | 4,273,000 |
| Receivables | 7,009,000 | 7,561,000 | 8,373,000 | 8,432,000 | 9,810,000 |
| Inventories | 2,143,000 | 1,960,000 | 1,909,000 | 2,061,000 | 1,852,000 |
| TOTAL | $16,007,000 | $16,697,000 | $20,335,000 | $19,048,000 | $23,506,000 |
| Non-Current Assets | |||||
| PPE Net | 6,413,000 | 6,010,000 | 5,818,000 | 6,089,000 | 6,425,000 |
| Investments And Advances | 989,000 | 1,026,000 | 646,000 | 588,000 | 543,000 |
| Intangibles | 34,446,000 | 32,531,000 | 26,028,000 | 26,346,000 | 20,842,000 |
| Other Non-Current Assets | 2,201,000 | 2,331,000 | 3,072,000 | 1,463,000 | 1,514,000 |
| TOTAL | $44,049,000 | $41,898,000 | $35,564,000 | $34,486,000 | $29,324,000 |
| Total Assets | $60,056,000 | $58,595,000 | $55,899,000 | $53,534,000 | $52,830,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 916,000 | 2,446,000 | 1,788,000 | 901,000 | 1,990,000 |
| Accounts payable and accrued liabilities | 11,663,000 | 11,886,000 | 10,362,000 | 9,221,000 | 8,975,000 |
| Other current liabilities | 807,000 | 644,000 | 825,000 | 919,000 | 1,397,000 |
| TOTAL | $14,869,000 | $17,330,000 | $16,051,000 | $13,903,000 | $15,752,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,137,000 | 8,397,000 | 8,588,000 | 9,409,000 | 7,338,000 |
| Other Non-Current Liabilities | 9,875,000 | 11,424,000 | 5,165,000 | 3,670,000 | 3,506,000 |
| TOTAL | $26,678,000 | $21,619,000 | $16,595,000 | $15,685,000 | $13,612,000 |
| Total Liabilities | $41,547,000 | $38,949,000 | $32,646,000 | $29,588,000 | $29,364,000 |
| Shareholders' Equity | |||||
| Common Shares | 316,000 | 316,000 | 315,000 | 312,000 | 323,000 |
| Retained earnings | 11,834,000 | 13,029,000 | 16,960,000 | 17,955,000 | 17,888,000 |
| Other shareholders' equity | 2,055,000 | 2,040,000 | 1,995,000 | 2,175,000 | 2,177,000 |
| TOTAL | $18,509,000 | $19,646,000 | $23,253,000 | $23,946,000 | $23,466,000 |
| Total Liabilities And Equity | $60,056,000 | $58,595,000 | $55,899,000 | $53,534,000 | $52,830,000 |